Enhanced Levels of Glycosphingolipid GM3 Delay the Progression of Diabetic Nephropathy

Enhanced Levels of Glycosphingolipid GM3 Delay the Progression of Diabetic Nephropathy

We recently found that albuminuria levels in patients with minimal change disease (MCD) and focal segmental glomerulosclerosis (FSGS) inversely correlate with glycosphingolipid GM3 expression levels in glomerular podocytes. Moreover, we showed enhanced expression of GM3 via activation of the GM3 syn...

Full description

Bibliographic Details
Main Authors: Shokichi Naito, Kenichi Nakayama, Nagako Kawashima
Format: Article
Language:English
Published: MDPI AG 2023-07-01
Series:International Journal of Molecular Sciences
Subjects:
glycosphingolipid GM3
valproic acid
diabetic nephropathy
albuminuria
podocyto injury
Online Access:https://www.mdpi.com/1422-0067/24/14/11355

Internet

https://www.mdpi.com/1422-0067/24/14/11355

Similar Items